You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

Welcome to ADVENT!

What do you want to know about type 2 inflammatory diseases?

No matches

ADVENT is a medical education program designed to advance the understanding of type 2 inflammation. ADVENT is developed in collaboration with over 50 global experts and links the latest science of type 2 inflammation with the clinical experience to improve patient care.

Educational resources

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

Pulmonology

17 min

expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Pulmonology

29 min

expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Gastroenterology

5 min

Infographic

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

17 min

Podcast

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Dermatology

42 min

expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Dermatology

5 min

Infographic

The Burden of AD: More Than Skin Deep

The Benefits of Early Intervention in AD: More Than Skin Deep

Dermatology

82 min

expert video

The Benefits of Early Intervention in AD: More Than Skin Deep

Learning hub

EoE

Check the new ADVENT EoE Learning Hub page to learn more about the pathophysiology, disease burden and management of EoE featuring educational resources.

Recently added

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Dermatology

16 min

expert video

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Type 2 Inflammation

11 min

expert video

The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis

Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid

Dermatology

12 min

expert video

Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid

Under the Itchy Surface: The Insidious, Cumulative Burden of Type 2 Inflammation in AD

Dermatology

14 min

expert video

Under the Itchy Surface: The Insidious, Cumulative Burden of Type 2 Inflammation in AD

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?

Dermatology

9 min

expert video

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

Dermatology

60 min

expert video

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

Chronic Spontaneous Urticaria Mechanism of Disease Animation

Dermatology

4 min

videoanimation

Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic dermatitis?

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis

Dermatology

20 min

Podcast

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis

Dermatology

3 min

expert video

Unmet Needs in Bullous Pemphigoid

Diagnosis and Clinical Manifestations of Bullous Pemphigoid

Dermatology

2 min

expert video

Diagnosis and Clinical Manifestations of Bullous Pemphigoid

Dermatology

4 min

expert video

Pathophysiology of Bullous Pemphigoid

Popular in United States

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

Pulmonology

5 min

interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

What Differentiates COPD Exacerbations From Asthma Exacerbations?

Pulmonology

2 min

expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD

Pulmonology

2 min

expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

On demand event highlights

6 assets

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

The March 2025 ADVENT symposium in Orlando, Florida brought together 4 dermatology experts to explore the evolving science of type 2 inflammation. Type 2 inflammation plays a central role in the pathophysiology of multiple dermatological diseases, driving chronic immune dysregulation that affects patients with atopic dermatitis (AD) prurigo nodularis (PN), chronic spontaneous urticaria (CSU) and bullous pemphigoid (BP). Understanding the mechanisms behind type 2 inflammation is key to advancing care and improving patient quality of life.

5 assets

Emerging Perspectives on the Disease Burden and Management of Children with Atopic Dermatitis

Join Christine Bangert and Perla Lansang for an educational symposium on atopic dermatitis (AD) in children, exploring the diagnosis and pathophysiology of AD in children, the life-long effects of uncontrolled disease beyond the skin, and current and emerging therapies.

Join Profs. Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller for an educational symposium exploring the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

2 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

Highlights from the ADVENT educational symposium at EADV 2024 where Professors Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller explored the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

Join experts Dedee Murrell, Donna Aline Culton, Joost Meijer and Enno Schmidt for an educational symposium on the clinical presentation, disease burden, diagnosis and pathophysiology of BP.

6 assets

Bullous Pemphigoid: Exploring New Frontiers

Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).

4 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Professors Klaus Rabe, Paola Rogliani, and Dr. Stephanie Christenson explore the complexity of inflammatory pathways and phenotypes in COPD. They provide insights into the genetic association of IL-33 with COPD, and discuss preclinical findings.

3 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz and Mona Bafadhel for an educational symposium exploring the role of type 2 cytokines in COPD and delve into the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden.

3 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

1 assets

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

3 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Presentation highlights from the ADVENT symposium on disease remission in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

1 assets

Global CRSwNP Awareness Day 2024

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

3 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

2 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Presentation highlights from the ADVENT symposium on smell loss and nasal congestion in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

3 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

3 assets

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Drs Sarina Elmariah and Mona Shahriari discuss the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncover how clinical signs and itch in these diseases are impacted by type 2 inflammation.

11 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

The following materials review the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient, improving clinical management and reducing long-term patient burden.

1 assets

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of biomarker assessments in guiding management strategies of recognizing the heterogeneity of COPD.

6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

Join Drs. James Del Rosso and Raj Chovatiya for an education program to explore the impact, contribution, and diagnosis of type 2 inflammation on atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

1 assets

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join Prof. Klaus Rabe and Dr. Stephanie Christenson for the educational symposium on type 2 inflammation in COPD presented at ERS 2023.

Explore all educational resources

Sign up to ADVENT

ADVENT is a medical education program dedicated to Type 2 Inflammation across multiple therapeutic areas. Registering for ADVENT is free and unlocks unlimited access to exclusive features and a wealth of content relevant to the practice of Dermatology, Pulmonology, Rhinology, and Gastroenterology. Sign up now!

Hear from ADVENT experts

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

On demand event highlights

6 assets

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

5 assets

Emerging Perspectives on the Disease Burden and Management of Children with Atopic Dermatitis

2 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

6 assets

Bullous Pemphigoid: Exploring New Frontiers

Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).

4 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

3 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

3 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

1 assets

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

3 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

1 assets

Global CRSwNP Awareness Day 2024

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

3 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

2 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

3 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

3 assets

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

11 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

1 assets

Anosmia Awareness Day 2024

3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

1 assets

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join Prof. Klaus Rabe and Dr. Stephanie Christenson for the educational symposium on type 2 inflammation in COPD presented at ERS 2023.

Explore all educational resources

Welcome to ADVENT!

Educational resources

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

The Burden of AD: More Than Skin Deep

The Benefits of Early Intervention in AD: More Than Skin Deep

Recently added

Inside the Hive: ​Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis

Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid

Under the Itchy Surface: The Insidious, Cumulative Burden of Type 2 Inflammation in AD

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

Chronic Spontaneous Urticaria Mechanism of Disease Animation

Type 2 Inflammation

Potential for Disease Modification in Atopic Dermatitis

Atopic Dermatitis as a Risk Factor for the Development of Food Allergies

Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic dermatitis?

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis

Unmet Needs in Bullous Pemphigoid

Diagnosis and Clinical Manifestations of Bullous Pemphigoid

Pathophysiology of Bullous Pemphigoid

Popular in United States

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD

On demand event highlights

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

Emerging Perspectives on the Disease Burden and Management of Children with Atopic Dermatitis

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

Bullous Pemphigoid: Exploring New Frontiers

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Global CRSwNP Awareness Day 2024

Lung Function White Board Videos

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

The Benefits of Early Intervention In AD: More Than Skin Deep

Anosmia Awareness Day 2024

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Sign up to ADVENT

Hear from ADVENT experts

Meet our experts

Katrina Abuabara

Seema Aceves

Alvar Agusti

Paolo Amerio

Peter Arkwright

April Armstrong

Ulrike von Arnim

Dhandapani Ashok

Leonard Bacharier

Claus Bachert

Vibeke Backer

Mona Bafadhel

Christine Bangert

Igor Barjaktarevic

Eulàlia Baselga

Eric Bateman

Lisa Beck

Anna Belloni Fortina

Thomas Bieber

Tilo Biedermann

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria